首页> 美国政府科技报告 >Evaluation of In Vitro Production of the Beta Chemokine, MCP-1, as a Diagnostic Test in diisocyante Asthma, with Cover Letter dated 03/03/1999
【24h】

Evaluation of In Vitro Production of the Beta Chemokine, MCP-1, as a Diagnostic Test in diisocyante Asthma, with Cover Letter dated 03/03/1999

机译:评估体外生产的β趋化因子mCp-1,作为二异氰酸酯哮喘的诊断试验,附件日期为03/03/1999

获取原文

摘要

The primary aim of this proposal is to validate dlisocyanate (DIISO) specific in vitro cellular MCP-1 as a diagnostic marker of occupational asthma (OA) by using the specific bronchoprovocation test (SBPT) as the gold standard for diagnosis. A secondary aim of the study is to evaluate the sensitivity and specificity ofin vitro serum DIISO-HSA specific IgG and IgE responses for identification ofdiisocyanate asthma (DA) confirmed by the SBPT. This report summarizes and discusses the results obtained in this study.

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号